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THE INFLUENCE OF CADMIUM IONS ON THE ADSORPTION OF PRO.
THROMBIN ONTO AI(OH)3 AS A MEANS TO PURTFY PROTHROMBTN
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Laboratory of Cardiovascular and Blood Coagulation Biochemistry, University Medical Centre, De-
partment of Internal Medicine, Leiden (The Netherlands)
(Received July 2nd, 1974)
SUMMARY
l. In the presence of CdSO4 (l mM), AI(OH)3 Q.3\wlv) completely adsorbs
the coagulation factors VII, IX, and X from normal plasma, but factor II (pro-
thrombin) is adsorbed for about 501only.
2. A purification procedure for factor I[ is developed, using A|(OH)3 adsorp-
tion in the presence of Cd2+ as a first step and using column chromatography only
once. A 750-fold purification is obtained at a24\yield.
3. Comparison of the prothrombin thus obtained, with prothrombin isolated
by the method of Kisiel and Hanahan (Biochim. Biophys. Acta (1973) 304, 103-l 13)
does not show significant differences in amino acid composition, N-terminal amino
acid, molecular weight or immunological properties.
4. Comparison of the tlvo prothrombin preparations in a thrombin-generating
system shows that although the final yield of thrombin from a given amount of
prothrombin in both preparations is the same, the initial velocity of thrombin for-
mation from our preparation is comparable to that of native prothrombin, whereas
the other preparation is converted significantly slower.
TNTRODUCTION
The four coagulation factors II, VII, IX, and X adsorb together onto many
inorganic powders. ln the presence of Cdz+, A|(OH)3 adsorbs less of prothrombin
than of the factors VII, lX, and X. This property can be used to purify prothrombin
in a procedure employing column chromatography only once.
MATERIALS AND METHODS
The following materials were used: DEAE-Sephadex A-50 lot number 3969,
and Dextran Blue 2000 from Pharmacia Fine Chemicals. Biogel P-100 polyacrylamide
gel filtration material from Biorad. Acrylamide and N,1y''-methylene bisacrylamide
* To whom all correspondence should be addressed at the Medica'l Faculty Maastricht,
Tongersestraat 53, Maastricht, The Netherlands.
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from Eastman Chemicals, New York, U.S.A. were recrystallised from chloroform
and acetone, respectively. Aluminum hydroxide was obtained as a moist gel (BDH
lot No. 7726301) and suspended in distilled water to a final concentration of 20/,
(w/v) immediately before use. Cadmium sulphate 3CdSO4'8H2O pro analysis and all
other chemicals (reagent grade) were obtained from Merck A.G., Darmstadt.
A standard plasma was obtained by mixing the plasma from 30 healthy
volunteers as described in ref. 1. Due to the l:10 dilution with the anticoagulant
sodium citrate solution this plasma is defined to contain 0.9 units per ml of each of
the coagulation factors.
Human plasma was obtained from blood collected on l/ I 0 volume of standard
acid-citrate-dextrose solution in siliconized glass bottles. The blood is centrifuged
for 20 min at 1500 x g.
The supernatant is then centrifuged for 30 min at 12 500 x g, which yields a
plasma with less than 100 thrombocytes per mm3.
A "euglobulin fraction" is obtained by diluting plasma 20-fold with twice
distilled water at 4 "C and adjusting to pH 5.2 with 0.1 M HCl. The precipitate is
collected by centrifugation (15 min,6000 x g,4'C) and dissolved in l/5 of the origi-
nal volume of veronal acetate buffer pH 7.35.
Prothrombin was also purified according to Kisiel and Hanahan [2). Echis
carinqta venom was obtained from Sigma. Staphylocoagulase was prepared according
to ref. 5. The concentration of protein in column eluants was monitored by recording
the adsorban ce at 286 nm. Protein was determined according to Lowry et al. [3] with
crystalline bovine serum albumin as a standard. For rapid protein measurement
either a biuret method [5] was used or, with column fractions, E2s0 was measured.
Elfiof prothrombin was taken to be 1.38 [2]. Amino acid analysis, determination of
the N-terminal amino acid and molecular weight determinations by gel filtration and
polyacrylamide gel electrophoresis in the presence of sodium dodecylsulphate were
carried out as described in ref. 5.
Thrombin concentrations are measured by mixing 0. I ml of sample (or, if ap-
propriate, sample in suitable dilution) with 0. I ml ol BaSOa-adsorbed bovine plasma
The clotting time is recorded and compared to the clotting time obtained with dilu-
tions of a standard preparation of thrombin. The thrombin generation experiments
were carried out as described in ref . 12. One-stage assays for factors V, VlI, and X
were carried out and evaluated as described in ref. 6. The two-stage assay for factor lI
was carried out and evaluated as described in ref. 7. Factor IX was estimated accord-
ing to ref. l. Determination of the prothrombin as the staphylocoagulase-reacting
l'actor was carried out as described in ref. 8.
Determination of prothrombin by means of Erhis corinato venom was carried
out in the same way, substituting a suitable concentration of the venom for staphylo-
coagulase. Tosyl arginine methyl esterase activity was assessed as described in ref. 9.
RESULTS
As can be seen from Fig. l, the presence of CdSOo specifically prevents the
adsorption of prothrombin from normal plasma onto 2 % (wlv) AI(OH)3, CdCl2 and
cadmium acetate show the same effect. Comparable results were obtained at other
AI(OH)3 concentrat ions.  Mn2+,  Ni2+,  Cu2+,  Fe2*,2n2+ were found not  to  in f luence
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Fig. L Influence of Cd2+ on the adsorption of coagulation factors onto Al(OH)r. CdSO+ was added
to normal plasma to the final concentration indicated. 2% (wlv) of AI(OH)3 was added, incubated
for 10 min and separated by centrifugation. The concentration of coagulation factors in the super-
natant was determined. O-O, factor II; |-O, factor X. The values for the factors VII and IX
were 0 at Cd2+ concentrations <1.4 mM and differed less than 5lfrom those for factor X, at higher
q.oncentrations; they are not represented.
the adsorption. We further purified the prothrombin not adsorbing onto AI(OH)3
in the presence of 1.0 mM Cd2+.
Purffication procedure
:. ' The entire procedure is carried out at 4'C. To the plasma are added succes-
sively 1/100 volume of a 0.1 M CdSO4 solution and l/15 Yolume of AI(OH)3 in the
form of a 20% (w/v) moist gel. After stirring for 10 min the AI(oH)3 is removed by
centrifugation for 15 min at 6000 X g. The Cd2 + from the supernatant (supernatanl a,
Table I) is removed by adding 3 g solid sodium oxalate per 100 ml, and centrifugation
(l5.min, 6000 x g) of the cadmium oxalate precipitate'
. From the supernatant (supernatant b, Table I) pibthrombin is adsorbed onto
20\ (wlv) A(OH)3 which is sedimented as above. The AI(OH)3 sediment is washed
first with 1/5 volume 0.1 M EDTA (pH 8.0) and then with l/5 volume 0.15 M NaCl.
The proteins adsorbed are eluted with ll2O volume 0.25 M sodium-potassium phos-
phate buffer (pH 8.0) and the AI(OH)3 is removed. The eluate is dialysed overnight
against 0.1 M NaCl in 0.01 M sodium-potassium phosphate buffer pH 6.8 and applied
to a 9 x I cm column containing DEAE-sephadex A-50 previously equilibrated
with 0.1 M NaCl in 0.01 M sodium-potassium phosphate buffer pH 6.8; 30 ml of
TABLE I
PURIFICATION OF HUMAN PLASMA FACTOR II
The figures are the means from 12 batches.
Fraction Vol.
(ml)
Activity Protein
(units/ml) concentration
(me/ml)
Spec. act. RecoverY
(unitsimg) (%)
Purification
(fold)
Plasma 500
Supernatant a 535
Supernatant b 535
Al(OH)a eluant 25
Sephadex A-50 44
0.83  68 .8
0.44 67.0
0.42 67.0
5.98 5.90
2.26 0.25
0.0121 100
0.0066 57
0.0063 54
1.014 36
9.O4 24
1.00
o.54
0.52
84
749
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matography; right hand gel :sample afterchromatography. The graph gives the coagulation times
in a factor II estimation as found with fragmented 2-mm segments of a gel obtained under the
same conditions as B.
this buffer is then followed by a linear gradient in the same buffer of 0.0-0.6 M in
NaCl (2 times 100 ml). Prothrombin elutes as a single peak at about 0.43 M NaCl.
The fractions containing more than 30\ of the original factor II actiyity are pooled.
Properties of the purified material
No factor VII, IX, or X activity was detectable in the final preparations; in
our assay systems (b) the limit of detectability is 0.0025 units/ml of the factors VII,
X, or IX in the presence of I unit/ml factor II.
Fig. 3. Immuno diffusion pattern with an antibody against prothrombin. The centre well contains
the antibody. The other wells contain human serum ( l), human plasma (2) and purified prothrombin
(3). Two types of the latter are tested, upper wells: preparation as described in this article; lower
wel l :  preparat ion according to Kis ie l  and Hanahan [2] .
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TABLE II
AMINO ACID COMPOSITION OF HUMAN
The figures give g amino acid per 100 g protein.
FACTOR II
Mean of four different preparations.
Amino acid Lanchantin [0] Hanahan [2] Present research
Lysine
Histidine
Arginine
Aspartic acid
Threonine
Serine
Glutamic acid
Proline
Glycine
Alanine
Cystine (half)
Valine
Methionine
Isoleucine
Leucine
Tyrosine
Phenylalanine
Tryptophan*
Totals
4.81
1.78
7.94
9.14
5.52
4.67
12.72
4.28
3.52
3.48
3.35
4. t5
1.30
3.42
6 .11
4.90
A A '
s.34
90.8s
5.19
l . 9 l
8.34
9.85
4.90
4.36
13.17
4.28
3.83
3 .  t )
2.51
4.53
1.29
3.30
6.52
4.31
5.07
3.28
90.39
4.85
1.98
8 . 1 8
9.89
5.21
4.25
13.36
4.50
3.75
3.61
3.84
4.53
1 . 3 8
3 , 1 8
6.48
4.95
3.80
3.09
90.83
" Determined according to Scoffone [16].
The isolated protein shows a single band on polyacrylamide-gel electrophoresis
(Fig. 2). An antibody raised against this preparation showed one precipitation arc
with normal human plasma continuous with both our preparation of purified pro-
thrombin and a preparation prepared according to Kisiel and Hanahan t2l (Fig. 3).
By gel filtration on Biogel P-100 a molecular weight of 74 000 f 2000 was
found (means of 15 experiments). On sodium dodecylsulphate-gel electrophoresis the
molecular weight appeared tobe72000 + 2500 (15 experiments) (see also ref.9).
upon incubation for 4 h at pH 7.5 and 37 "c both our preparation and that
prepared according to Kisiel and Hanahan were stable as judged from the degradation
products detectable in sodium dodecylsulphate-gel electrophoresis. Upon the addition
TABLE I IT
SPECIFIC ACTIVITY OF PURIFIED PROTHROMBIN
The figures give specific activities in units per mg. A, preparation as described in this article (means
of 12 experiments); B, preparation according to Kisiel and Hanahan [2] (means of 2 batches),
Method Preoaration
One-stage
Two-stage
Staphylocoagulase
Echis carinata
9.O4 s.34
9.06 9.34
9.07 9.02
9.01 8.98
l
I
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of I unit/ml of human thrombin both preparations broke down within 30 min to
50000 and23 000 mol. wt subunits, which is in accordance with the literature [17].
The amino acid composition is not essentially different from that of the human
prothrombin purified by Kisiel and Hanahan [2] and Lanchantin [10] (Table II).
Alanine was found as the N-terminal amino acid. The final preparation contained
no traceable amounts of Cd2+. In Table III the specific activities obtained with four
different methods of assaying prothrombin are compared for the preparation de-
scribed here and that described by Kisiel and Hanahan [2].
The two preparations were also compared as to the velocity of thrombin for-
mation by a fixed high concentration of prothrombinase [12]. The concentrations of
the preparations were adjusted so as to yield eventually the s€rme amount of thrombin
(Fig. a).
Fig. 4. Velocity of thrombin generation from various preparations of prothrombin. At zero time afixed high amount of prothrombinase is added to a prothrombin preparation. The incubation isdone at 37 "C- At 2min intervals 0.I-ml aliquots of ihe incubation mixture are assayed for theirthrombin content. N, euglobulin preparation from normar plasma; D, prothrombin preparation asdescribed in this article; K, prothrombin preparation prepared according to rel.2; A, euglobulinpreparation from patients under deep oral anticoagulation. The final throi-rbin yield was assessed inpreliminary experiments. The preparations were diluted so as to gain the same final thrombin con-centration in this experiment.
Also included in this experiment is the thrombin generation from an acid-
precipitated euglobulin fraction from the plasma of normal subjects and of patients
under deep oral anticoagulation.
Acid precipitation was necessary as it is compulsory in this type of experiment
to remove antithrombin 3. These preparations were included in order to compare
the velocity of thrombin generation from the purified preparations with that of
normal prothrombin that has undergone a minimum of manipulations on the one
hand, and with the protein induced by vitamin K absence analtgous to factor lI on
the other  [2] .
In order to check the preparations for traces of thrombin, the preparation was
incubated with an "euglobulin" fraction of BaSOn-adsorbed normal oxalated plasma
neither containing antithrombin 3 nor the factors Il, vll, IX, and X, but ii"h in
factor v (l5o%) and facror vrII (lg5 %); no activation of these factors could be
observed.
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In a solution containing 200 p,glml of prothrombin and 5'10-3 M tosyl-
arginine methyl ester, less than 5'10-8 g equiv. was split in 10 min' Under the same
cirLmstances 1 prg of thrombin (2.5 N.LH. units) per ml will split 1.5'10-6 g equiv.
of the ester.
DISCUSSION
The prothrombin that does not adsorb to A1(OH)3 in the presence of I mM
cdso4 couid not be distinguished from the prothrombin described by Kisiel and
Hanalian [2] on the basis ofamino acid composition, N-terminal 
amino acid, immu-
nological properties or molecular weight. There are certain differences between the
two prepaiations, however, in the kinetics of thrombin generation.- 
We confirmed the discrepancy between the one-stage and the two-stage deter-
mination of factor II activity in prothrombin prepared according to Kisiel and
Hanahan, but did not find it in our preparation (Table III)'
ln a one-stage assay the initial rate of thrombin generation determines the
outcome of the estimate [11] whereas in the two-stage assay the total eventual 
yield
of thrombin determines the result [7]. A two-stage assay showing higher activities
than a one-stage assay, therefore, indicates that there may be prothrombin molecules
present that do not (or only partially) contribute to the initial rate of thrombin
ieneration whereas they do contribute to the final thrombin 
yield [12].
with a fixed high amount of prothrombin-converting enzyme (prothrombinase)
present, and with the prothrombin concentrations adjusted so as to give the same
hnal thrombin yield, the thrombin generation from the preparation of Kisiel and
Hanahan indeed is significantly slower than that from our preparation (Fig. a)'
We compared the kinetic properties of the purified preparations to those of
comparatively unmanipulated prothrombin and of the protein induced by vitamin K
absence analogous to iactor f lllfVfA-tl) p3, 141. Like the prothrombin of Kisiel
and Hanahan, PIVKA-II shows a discrepancy between the one-stage and the two-
stage assay [12]. Also the velocity of thrombin generation from PIVKA-II 
is much
slower than that from normal prothrombin (ref. 12: Fig. 4)' It is thought that the
difference between PIVKA-II and normal prothrombin lies in the fact that in normal
prothrombin several glutamic acid residues have been converted into 7-glutamyl
glutamic acid residues by a vitamin K-dependent system [15]. fn PIVKA-II the-y-carboxy 
glutamic acid residues are absent, which makes this protein a bad substrate
for prothrombinase.
It is tempting to attribute the observed kinetic properties of the Kisiel and
Hanahan prothrombin preparation to the loss of one or more 7-carboxyl groups
from the piothrombin moleiule during the purification procedure. Alternatively, one
might suspect the rapid generation of thrombin in our preparation to be caused by
trace amounts of thrombin acting upon factor V in the prothrombinase preparation'
The complete absence of any activaiion of the factors V and VIII by'our preparation
and the absence of an autodigestion pattern as would be obtained if thrombin were
present makes this explanation much less likely. From the Tos-Arg-OMe esterase
activity of the preparalion it can be concluded that less than 0.05 prg thrombin 
per
100 prg of prothrombin is present in our preparation'
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